- Home
- BBIO vs FTEL Comparison
BBIO vs FTEL Comparison
Compare BBIO & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- FTEL
- Stock Information
- Founded
- BBIO 2015
- FTEL 2007
- Country
- BBIO United States
- FTEL Australia
- Employees
- BBIO N/A
- FTEL N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- FTEL
- Sector
- BBIO Health Care
- FTEL
- Exchange
- BBIO Nasdaq
- FTEL Nasdaq
- Market Cap
- BBIO 6.7B
- FTEL 9.6M
- IPO Year
- BBIO 2019
- FTEL 2023
- Fundamental
- Price
- BBIO $34.17
- FTEL $0.52
- Analyst Decision
- BBIO Strong Buy
- FTEL
- Analyst Count
- BBIO 12
- FTEL 0
- Target Price
- BBIO $57.09
- FTEL N/A
- AVG Volume (30 Days)
- BBIO 3.1M
- FTEL 103.3K
- Earning Date
- BBIO 04-29-2025
- FTEL 05-20-2025
- Dividend Yield
- BBIO N/A
- FTEL N/A
- EPS Growth
- BBIO N/A
- FTEL N/A
- EPS
- BBIO N/A
- FTEL N/A
- Revenue
- BBIO $127,415,000.00
- FTEL $4,990,695.00
- Revenue This Year
- BBIO $13.67
- FTEL N/A
- Revenue Next Year
- BBIO $118.02
- FTEL N/A
- P/E Ratio
- BBIO N/A
- FTEL N/A
- Revenue Growth
- BBIO N/A
- FTEL 29.02
- 52 Week Low
- BBIO $21.62
- FTEL $0.43
- 52 Week High
- BBIO $39.47
- FTEL $49.50
- Technical
- Relative Strength Index (RSI)
- BBIO 44.19
- FTEL 37.45
- Support Level
- BBIO $33.92
- FTEL $0.61
- Resistance Level
- BBIO $39.16
- FTEL $0.55
- Average True Range (ATR)
- BBIO 1.50
- FTEL 0.06
- MACD
- BBIO -0.24
- FTEL 0.04
- Stochastic Oscillator
- BBIO 10.35
- FTEL 47.35
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.